GenericsFrom Approval to Acceptance: Teva Expands Portfolio with PONLIMSI™ and Xo... From Approval to Acceptance: Teva Expands Portfolio with PONLIMSI™ and Xo... Read Post »
Health TidingsScholar Rock Resubmits Apitegromab BLA to FDA Scholar Rock Resubmits Apitegromab BLA to FDA Read Post »
Drugs Safety AlertFDA Flags Fatal Liver Injury, Including VBDS, with Tavneos (avacopan) FDA Flags Fatal Liver Injury, Including VBDS, with Tavneos (avacopan) Read Post »
Clinical TrialsAstra Zeneca’s Efzimfotase Alfa Shows Phase III Benefit in HPP, With Mixe... Astra Zeneca’s Efzimfotase Alfa Shows Phase III Benefit in HPP, With Mixe... Read Post »
Health Tidings Mergers & AcquisitionsBiogen’s $5.6B Apellis Deal Boosts Immunology and Rare Disease Portfolio Biogen’s $5.6B Apellis Deal Boosts Immunology and Rare Disease Portfolio Read Post »
Health Tidings Mergers & AcquisitionsGalapagos – Gilead Finalize Ouro-Linked Deal to Advance Gamgertamig Galapagos – Gilead Finalize Ouro-Linked Deal to Advance Gamgertamig Read Post »
Clinical TrialsConnect’s Rademikibart Shows Rapid, Sustained FEV1 Improvement Connect’s Rademikibart Shows Rapid, Sustained FEV1 Improvement Read Post »
Clinical TrialsUnited Therapeutics’ Tyvaso Surpasses TETON-2 with Strong TETON-1 IPF Res... United Therapeutics’ Tyvaso Surpasses TETON-2 with Strong TETON-1 IPF Res... Read Post »
Clinical TrialsMerck’s Oral PCSK9 Candidate Enlicitide Cuts LDL-C by 64.6% in Phase 3 Ad... Merck’s Oral PCSK9 Candidate Enlicitide Cuts LDL-C by 64.6% in Phase 3 Ad... Read Post »
Clinical TrialsTanabe’s Dersimelagon Improves Sunlight Tolerance in Phase 3 Study in Rar... Tanabe’s Dersimelagon Improves Sunlight Tolerance in Phase 3 Study in Rar... Read Post »
Mergers & AcquisitionsLilly to Acquire Centessa in $6.3B Deal, Expands Orexin Pipeline for Sleep ... Lilly to Acquire Centessa in $6.3B Deal, Expands Orexin Pipeline for Sleep ... Read Post »
Clinical TrialsWith 3-Dose Regimen, Viridian’s Elegrobart Shows Breakthrough Potential i... With 3-Dose Regimen, Viridian’s Elegrobart Shows Breakthrough Potential i... Read Post »
Health TidingsAquestive Aligns with FDA on Anaphylm NDA Resubmission, Aim Q3 2026 Filing Aquestive Aligns with FDA on Anaphylm NDA Resubmission, Aim Q3 2026 Filing Read Post »
Health TidingsEU Expands Kerendia Label: Bayer’s Finerenone Approved for Broader Heart ... EU Expands Kerendia Label: Bayer’s Finerenone Approved for Broader Heart ... Read Post »
Clinical TrialsConnect Biopharma Joins AAD Wave with Strong Phase 3 Rademikibart Data in A... Connect Biopharma Joins AAD Wave with Strong Phase 3 Rademikibart Data in A... Read Post »
Clinical TrialsBeyond Adults: Idorsia’s Daridorexant Shows Promise in Pediatric Insomnia Beyond Adults: Idorsia’s Daridorexant Shows Promise in Pediatric Insomnia Read Post »
Health Tidings Mergers & AcquisitionsAfter NVIDIA, Lilly Signs New AI Drug Discovery Deal with Insilico After NVIDIA, Lilly Signs New AI Drug Discovery Deal with Insilico Read Post »
Clinical TrialsBMS Reports Stable Cobenfy Switch Data and Positive Phase 3 Camzyos Results... BMS Reports Stable Cobenfy Switch Data and Positive Phase 3 Camzyos Results... Read Post »
Health TidingsFDA Clears IND for Sialic Acid Prodrug UX016 in GNEM FDA Clears IND for Sialic Acid Prodrug UX016 in GNEM Read Post »
Health TidingsAmgen’s Repatha Lowers First CV Risk in High-Risk Patients Amgen’s Repatha Lowers First CV Risk in High-Risk Patients Read Post »
New Drug ApprovalBiogen’s High-Dose Spinraza Approved by FDA Backed by DEVOTE Data Biogen’s High-Dose Spinraza Approved by FDA Backed by DEVOTE Data Read Post »
Clinical TrialsBiogen’s Litifilimab Shows Phase 2 AMETHYST Success in Cutaneous Lupus Biogen’s Litifilimab Shows Phase 2 AMETHYST Success in Cutaneous Lupus Read Post »
ResearchCorcept MOMENTUM Study Finds 27% Hypercortisolism in Resistant Hypertension Corcept MOMENTUM Study Finds 27% Hypercortisolism in Resistant Hypertension Read Post »
Health TidingsSanofi’s Sarclisa SC Gets CHMP Nod with OBI Option Sanofi’s Sarclisa SC Gets CHMP Nod with OBI Option Read Post »
Health TidingsAfter FDA Approval, J&J Shows Durable 52-Week ICOTYDE Results in Psoria... After FDA Approval, J&J Shows Durable 52-Week ICOTYDE Results in Psoria... Read Post »
Health TidingsPriovant’s Brepocitinib Gains Priority Review After Phase 3 Success Priovant’s Brepocitinib Gains Priority Review After Phase 3 Success Read Post »
Health TidingsNovartis’ Fabhalta Cuts Kidney Function Decline by 50% in Phase 3 Novartis’ Fabhalta Cuts Kidney Function Decline by 50% in Phase 3 Read Post »
Health TidingsBIMZELX Shows Durable Remission in Psoriasis and Sustained 3-Year Control i... BIMZELX Shows Durable Remission in Psoriasis and Sustained 3-Year Control i... Read Post »
Clinical TrialsTakeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Results ... Takeda’s Oral TYK2 Inhibitor Zasocitinib Delivers Strong Phase 3 Results ... Read Post »
Clinical TrialsIncyte Reports Strong 1-Year Data for Povorcitinib in Hidradenitis Suppurat... Incyte Reports Strong 1-Year Data for Povorcitinib in Hidradenitis Suppurat... Read Post »
Clinical TrialsTaltz+Zepbound Outperforms Taltz Alone in PsA Patients with Obesity Taltz+Zepbound Outperforms Taltz Alone in PsA Patients with Obesity Read Post »
Clinical TrialsLilly’s EBGLYSS Reinforces Long-Term Disease Control in Atopic Dermatitis Lilly’s EBGLYSS Reinforces Long-Term Disease Control in Atopic Dermatitis Read Post »
Clinical TrialsSanofi Reports Phase 3 Success for Amlitelimab in Atopic Dermatitis Sanofi Reports Phase 3 Success for Amlitelimab in Atopic Dermatitis Read Post »
Health TidingsOrganon Highlights Week 1 Improvements with VTAMA in Atopic Dermatitis Organon Highlights Week 1 Improvements with VTAMA in Atopic Dermatitis Read Post »
Health TidingsFDA Clears Lantern–Starlight STAR-001 Study in Pediatric Brain Cancer FDA Clears Lantern–Starlight STAR-001 Study in Pediatric Brain Cancer Read Post »
Clinical TrialsLenvima, Welireg Moves Closer to Approval with Japan Submission Lenvima, Welireg Moves Closer to Approval with Japan Submission Read Post »
New Drug ApprovalCHMP Recommends Five New Medicines for EU Approval in March 2026 CHMP Recommends Five New Medicines for EU Approval in March 2026 Read Post »
Health TidingsOtsuka Seeks Japan Approval for First-Line Use of Iclusig in Ph+ ALL Otsuka Seeks Japan Approval for First-Line Use of Iclusig in Ph+ ALL Read Post »
Clinical TrialsAstraZeneca Reports Positive Phase III Data for Tozorakimab in COPD AstraZeneca Reports Positive Phase III Data for Tozorakimab in COPD Read Post »
Health TidingsGSK’s Bepirovirsen Accepted by EMA for Review in Chronic Hepatitis B GSK’s Bepirovirsen Accepted by EMA for Review in Chronic Hepatitis B Read Post »
Mergers & AcquisitionsNovartis to Acquire Excellergy for Up to $2 Billion, Adds Next-Generation A... Novartis to Acquire Excellergy for Up to $2 Billion, Adds Next-Generation A... Read Post »
New Drug ApprovalChina Approves ENHERTU as First HER2 ADC for Neoadjuvant Breast Cancer China Approves ENHERTU as First HER2 ADC for Neoadjuvant Breast Cancer Read Post »
Mergers & AcquisitionsOtsuka to Acquire Transcend Therapeutics in Up to $1.2B Deal to Advance PTS... Otsuka to Acquire Transcend Therapeutics in Up to $1.2B Deal to Advance PTS... Read Post »
Health Tidings Mergers & AcquisitionsBiogen Signs Deal with Alteogen to Develop Subcutaneous Versions of Two Bio... Biogen Signs Deal with Alteogen to Develop Subcutaneous Versions of Two Bio... Read Post »
Clinical TrialsWave’s RNA Therapy WVE-007 Shows Early Fat-Loss Signal in INLIGHT Trial Wave’s RNA Therapy WVE-007 Shows Early Fat-Loss Signal in INLIGHT Trial Read Post »
GenericsNovo Nordisk Sues Dr. Reddy’s Over “Olymviq” Name, Says It Too Closel... Novo Nordisk Sues Dr. Reddy’s Over “Olymviq” Name, Says It Too Closel... Read Post »
New Drug ApprovalNovo Nordisk Wins FDA Approval for Once-Weekly Basal Insulin Awiqli Novo Nordisk Wins FDA Approval for Once-Weekly Basal Insulin Awiqli Read Post »
New Drug ApprovalFDA Grants Accelerated Approval to Rocket’s Kresladi Gene Therapy for... FDA Grants Accelerated Approval to Rocket’s Kresladi Gene Therapy for... Read Post »
Health TidingsOno Submits Ripretinib for Approval in Japan to Treat Advanced Gastrointest... Ono Submits Ripretinib for Approval in Japan to Treat Advanced Gastrointest... Read Post »
Medical DevicesNovocure Reports Encouraging Phase 2 Data for TTFields in Pancreatic Cancer Novocure Reports Encouraging Phase 2 Data for TTFields in Pancreatic Cancer Read Post »
